Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Transl Res. 2015 Jan 13;166(1):57–69. doi: 10.1016/j.trsl.2015.01.001

Figure 4. Pro-inflammatory cytokine levels in BALF following single DE exposure in mice receiving pretreatment with MaR1 given intranasally.

Figure 4

Mice were pretreated with 0 or 1 ng MaR1 given i.n. at 18 hrs and 30 minutes prior to a single intranasal dose of DE. At five hours following DE exposure, BALF were retrieved and analyzed for IL-6 (A), TNF-α (B), CXCL1 (C), and CXCL2 (D) cytokine levels. ### p < 0.001 compared to vehicle + saline group; ## p < 0.01 compared to vehicle + saline group; # p < 0.05 compared to vehicle + saline group; ** p < 0.01 versus DE treatment group; * p < 0.05 versus DE treatment group. Data are represented as mean values with standard error bars. N ≥ 5 mice per group.